CURRENT CONCEPTS ABOUT POSSIBILITIES OF DRUG THERAPY OF PATIENTS WITH TRIPLE NEGATIVE BREAST CANCER

The data about molecular-biological features of triple negative subtype breast cancer (BC), the results of the medicinal treatment of patients and new approaches to classic chemo- and target therapy are analyzed. Triple negative breast cancer is a disease, in the last decade actively studied and discussed in world literature, which is characterized by aggressiveness of clinical flow and insignificant number of molecular targets, providing a stable answer for medicinal influence. However detailed study of this subtype of BC and search on this basis of new facilities and charts of medicinal treatment allow to expect much optimizations of results of the last.